As Roche works to switch certain patients with breast cancer over to a fixed-dose combination of two medicines, its ...

Organon CEO Kevin Ali has stepped down from his leading position at the company, following its board’s discovery of sales malpractice. This follows a probe from the board’s audit committee, which ...

In the latest close session, Organon (OGN) was up +1.23% at $9.05. The stock's performance was ahead of the S&P 500's daily gain of 0.58%. Meanwhile, the Dow experienced a rise of 0.31%, and the ...

Some four years into its run as an independent women’s health outfit, Organon is parting ways with its first CEO after an internal probe turned up evidence of suspect sales practices at the Merck ...

Oct 27 (Reuters) - Organon (OGN.N), opens new tab said on Monday CEO Kevin Ali will resign from his role, after an internal investigation into sales of its Nexplanon contraceptive implant to ...

Organon's CEO resignation follows an investigation into incentivized excess Nexplanon sales to U.S. wholesalers, impacting revenue metrics. The investigation found these sales represented less than 1% ...

Investing.com -- Organon (NYSE:OGN) stock plunged 18% after the company announced CEO Kevin Ali’s resignation following an internal investigation that uncovered improper wholesaler sales practices for ...

Organon & Co. shares plunged after an internal probe revealed questionable practices related to Nexplanon sales to wholesalers in 2022, 2024, and the first nine months of 2025. In this article, I ...

Organon & Co. shares plunged Monday, October 27th, after CEO Kevin Ali resigned amid an audit committee investigation into wholesaler sales irregularities. Despite the scandal, OGN's valuation at $7 ...

Organon said its chief executive, Kevin Ali, has stepped down following an internal investigation into sales practices for the company's Nexplanon birth-control implant. The Jersey City, N.J., company ...

Organon (NYSE: OGN) (“Organon” or “the company”) today announced that its Board of Directors has appointed the Company’s Executive Vice President and Head of Manufacturing & Supply, Joseph Morrissey, ...

Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation Organon (NYSE: OGN) (“Organon” or ...